Summary Resistance to chemotherapy is a major problem in the treatment of patients with head and neck squamous cell carcinoma (HNSCC). Important factors involved are drug detoxification by glutathione (GSH) and reduced drug accumulation due to active transport out of the cell by so-called 'multidrug resistance-related proteins'. We have studied a panel of eight HNSCC cell lines showing differences in sensitivity to the anti-cancer drug cisplatin. Our previous studies indicated that the IC50 values were inversely correlated with the intracellular accumulation of platinum (Pt). In the present study, cellular GSH levels were found not to be related to the IC50 values. The expression levels of the enzymes glutathione S-transferase (GST) a, ,u and it, the multidrug resistance-related proteins P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and the lung resistance protein (LRP) were determined semiquantitatively by means of immunocytochemistry. The levels of the GSTs, P-gp and LRP were not found to be correlated with the IC50 values of the HNSCC cell lines. Surprisingly, however, an inverse correlation was found between MRP levels and IC50 values. The MRP expression levels were in agreement with the results of the MRP functional assay, based on the transport of calcein across the cell membrane as performed for two of the cell lines. Further studies should prove whether other pump mechanisms or DNA repair are involved in the cisplatin accumulation and the subsequent HNSCC cell growth inhibition.
membranes into vesicles and out from the cell. A number of substrates are transported by MRP after conjugation to GSH (Muller et al, 1994) . Another MDR-associated protein, recently discovered, is the lung resistance protein (LRP), possibly mediating intracellular transport (Scheper et al, 1993; Scheffer et al, 1995) . Although cisplatin is not known to induce MDR itself, MDR-induced cells can become cross-resistant to cisplatin (Loe et al, 1996) . The possible involvement of MDR in the response to platinum (Pt)-based treatments has been reported in a panel of 61 human cell lines of eight different cancer types (Izquierdo et al, 1996a) and in patients with ovarian cancer . HNSCC was not included in these studies, although other studies have shown that HNSCC cells can express P-gp (Kelley et al, 1993) , MRP (Nooter et al, 1995) , as well as LRP (Izquierdo et al, 1996b) .
Using a panel of eight HNSCC cell lines that differ in cisplatin sensitivity, we were able to show an inverse correlation between IC50 values and Pt accumulation (Welters et al, 1997) . To investigate the underlying mechanism of differences in cisplatin sensitivity and Pt accumulation, we presently report on the GSH levels and the expression levels of the GST isoenzymes as well as of the MDR proteins P-gp, MRP and LRP. In addition, the MRP activity was determined.
MATERIAL AND METHODS Tumour cell lines Human HNSCC cell lines UM-SCC-IIB, UM-SCC-14C, UM-SCC-22A, UM-SCC-22B and UM-SCC-35 were described by Carey et al (1990) . These cell lines were established from fresh tumour biopsies. The same holds for cell lines 92VU040T and 93VU120T (Hermsen et al, 1996) . VU-SCC-OE was established in our laboratory from a HNSCC xenograft (Welters et al, 1997) . Cells were routinely cultured in Dulbecco's modified Eagle medium (Life Technologies, Gibco BRL, Breda, The Netherlands) supplemented with 5% heat-inactivated fetal calf serum (Flow, Irvine, UK), 50 U ml' penicillin and 50 g ml' streptomycin (Life Technologies).
Cisplatin treatment HNSCC cells at subconfluency were treated with cisplatin for 72 h, washed twice with phosphate-buffered saline (PBS) and harvested by use of trypsin. The IC50 data of the HNSCC cells, i.e. the concentration of the drug causing 50% of growth inhibition compared with that of untreated control cells, have been published before (Welters et al, 1997) and were determined with the sulphorhodamine B (SRB) assay (Braakhuis et al, 1993) .
GSH content in cultured human HNSCC cells GSH was measured in untreated and cisplatin-treated HNSCC cells by high-performance liquid chromatography (HPLC) combined with precolumn derivatization with orthophthaldehyde and fluorometric detection (Neuschwander-Tetri and Roll, 1989) . GSH levels per cell line were measured in two or three independent samples of cells cultured at subconfluency.
Immunocytochemical staining of GST isoenzymes
Expression of the GST isoenzymes cc, ,u and it was analysed using the immunoperoxidase staining method described by Bongers et al (1995) . HNSCC cells were deposited on glass slides with a cytospin centrifuge, fixed with methanol for 10 min and washed with PBS. A 30-min preincubation was performed with 2% normal swine serum (Dako, Copenhagen, Denmark) diluted in PBS containing 1% bovine serum albumin (BSA; Sigma, St Louis, MO, USA), followed by incubation with rabbit antisera directed aThe sensitivity to cisplatin was determined by a cell proliferation (SRB)
assay. The IC50 value, the concentration of the drug causing 50% growth inhibition after a 72-h treatment, is given in gM cisplatin. These results were obtained in a previous study and were reported to be significantly correlated with Pt accumulation data when those of cell line OE were omitted (Welters et al, 1997) . bThe total amount of Pt accumulated in the cells (expressed as pmol Pt per 106 cells), after treatment with 10 gM of cisplatin for 72 h, was determined with AAS in a previous study (Welters et al, 1997) . cGlutathione (GSH) levels (fmol per cell) were determined by HPLC according to Neuschwander-Tetri et al (1989) against GST-oc, -jt and -x respectively (antisera diluted 1:1 in PBS/1% BSA; NovoCastra, Newcastle upon Tyne, UK). The preparations were washed three times with PBS (5 min each), and treated for 10 min with 0.006% hydrogen peroxide in methanol to inhibit endogenous peroxidase activity, followed by three washings with PBS. Immunocytochemical staining of P-gp, MRP and LRP
The HNSCC cells were cultured until subconfluency and harvested onto cytocentrifuge slides, which were stored at -20°C until analysis. Immunocytochemistry was performed as described by Izquierdo et al (1996b) . In short, after thawing the cytocentrifuge preparations were acetone-fixed (10 min) before preincubation with 2% normal rabbit serum for 15 min (Dako). Then, slides were incubated for 60 min at room temperature with one of the following monoclonal antibodies (MAb): mouse MAb JSB-1 (1:100 of 10 ,ug ml-') against P-gp, mouse MAb MRP-m6 (1:25 of 1 ug ml-') and rat MAb MRP-rl (1:1500 of 1 jg ml-') against MRP, rat MAb LRP-56 (1:500 of 0.5 ,ug ml-') and LMR-5 (1:500 of 0.5,g ml-') both directed against LRP. These antibodies are available from Sanbio, Uden, The Netherlands. After washing with PBS for 15 min, the slides were incubated for 60 min with rabbit anti-mouse biotin (1:150; Zymed Laboratories, San Francisco, CA, USA) or rabbit anti-rat biotin (1:100) conjugate (Dako), washed and incubated with streptavidin coupled to horseradish peroxidase (1:500; Zymed Laboratories) for 60 min. All dilutions were in PBS with 1% BSA. The washed cells were finally stained with amino-ethyl-carbazole (ICN Biochemicals, Aurora, OH, USA) for 5 min and counterstained with haematoxylin (Merck). As a negative control, irrelevant IgG or PBS was used instead of the primary antibody. Positive controls for the expression of each of the proteins were KB-8-5 cells for P-gp , GLC4/ADR cells for MRP and SW-1573/2R 120 cells for LRP (Scheper et al, 1993; Flens et al, 1994; Broxterman et al, 1996) . Immunohistochemical staining of the cell lines was performed in two independent experiments (I and II) and all slides of each experiment were stained simultaneously.
Evaluation of immunocytochemical staining
The evaluation was performed using light microscopy on coded slides. Scoring of each immunocytochemical experiment was performed blindly and independently by three observers. of each group was calculated as the product of this percentage and the staining intensity. The latter was estimated on a scale of 1 (+)
to 3 (+ + +). The variation in scores between the three observers, expressed as a coefficient of variation, i.e. the s.d. as a percentage of the mean, was always less than 30%. Intraobserver variation of scoring was tested and was proved to be less than 20%.
Functional MRP test
The HNSCC cell lines UM-SCC-14C that showed a low sensitivity to cisplatin and UM-SCC-35, the most sensitive cell line of our panel, were analysed in two independent experiments for the presence of functional MRP as described by Feller et al (1995) . Briefly, about 0.5 x 106 cells were allowed to take up calceinacetoxymethylester (calcein-AM) by incubation in 0.5 ,UM of this dye for 10 min at 37°C. They were washed and subsequently incubated in fresh medium with or without the MRP inhibitor probenecid (1.0 mm, Sigma) for 0, 10 or 60 min. The efflux was stopped by centrifugation of the cells and addition of ice-cold culture medium. In this assay, the non-fluorescent dye calcein-AM is converted by intracellular esterases to the fluorescent calcein. The calcein can be exported by active MRP, which can be prevented by the use of the MRP inhibitor. The intracellular calcein is then analysed using FACScan flow cytometry (Becton Dickinson Medical Systems, Sharon, MA, USA). The human small-cell lung cancer cell line GLC4, which is MRP negative, and its MRP-overexpressing subline GLC4/ADR were used as controls (Feller et al, 1995 staining. Over 90% of the cells of each line were positive for GSTit. The staining percentages for the other two GST isoenzymes were lower and varied considerably between the cell lines. For GST-at the percentage of positively stained cells varied between 15% and 100%, whereas for GST-,u it varied from 3% to 100%. The calculated staining indices (see Material and methods) differed between the cell lines and between the three isoforms of GST, but none of these correlated with the IC50 values (Table 2) , neither with the Pt accumulation in these cells after 72 h of exposure to cisplatin nor with the GSH levels determined in the untreated cells.
Expression of MDR-related proteins
The expression level of the MDR protein P-gp, visualized by use of antibody JSB-1, was expressed in all HNSCC cell lines tested, with staining index ranging from 128 (93VU120T) to 262 (UM-SCC-35). The levels of MRP, measured with specific mouse and rat antibodies, were also different for the various HNSCC lines. The UM-SCC-14C cells appeared to be stained very weakly or not at all, indicating that MRP levels were relatively low. The data obtained with the mouse and rat anti-MRP antibodies were correlated significantly, resulting in a correlation coefficient (r-value) of 0.72 (P = 0.05) in the first and r = 0.80 (P = 0.04) in the second experiment. The staining index of LRP-56, a measure of the presence of LRP, ranged from 107 for UM-SCC-14C cells to 202 for cell line UM-SCC-35. With the LMR-5 antibody, which also recognizes LRP, similar variations in staining level were observed. The results obtained with these two antibodies recognizing LRP did significantly correlate in the two experiments (r = 0.63, P = 0.02 and r = 0.72, P = 0.05).
To find out whether the levels of these three membrane proteins have an effect on the sensitivity of the cells to cisplatin, the relationships between these levels and the IC50 values were determined. A significant inverse correlation was found in the first experiment between the IC50 values and MRP, as indicated by the staining index of MRP-m6 (r = -0.79, P = 0.04) and of MRP-rl (r = -0.83, P = 0.03) (see Fig. IA and Table 2 ). The second experiment (Fig IB) (Table 2) .
Whether or not the total amount of Pt accumulated in the HNSCC cells (with the exception of VU-SCC-OE) is correlated with the expression levels of MRP as visualized with antibody MRP-m6 is not quite clear. In the first experiment, the correlation was found not to be significant (r = 0.68, P = 0.09), but in the second experiment it was significant (r = 0.89, P = 0.03). The same holds true for the results obtained with the other MRP-recognizing antibody, showing a significant correlation between Pt accumulation levels and MRP-rl staining results, in experiment I (r = 0.77, P = 0.05) and no significance in experiment II (r = 0.61, P = 0.13).
Functional MRP test
Cell lines UM-SCC-14C and UM-SCC-35, which differed significantly in MRP expression, were used to determine if the established differences in the levels of MRP were indicative for differences in the MRP activity in the cells. The results of the assay are given in Table 3 . The UM-SCC-14C cells showed hardly any activity of the MRP pump, whereas the cells of line UM-SCC-35 appeared to have functional MRP after 10-min and 60-min treatments determined with the MRP inhibitor probenecid. This is in agreement with the immunocytochemical staining results, in which the presence of MRP could not be demonstrated in UM-SCC-14C cells whereas a relatively high expression was observed in UM-SCC-35.
DISCUSSION
Our data indicate a minor role for GSH as a determining factor of the differences in sensitivity to cisplatin of the presently studied HNSCC cell lines. An inverse correlation between the GSH levels and cisplatin sensitivity has been reported for cell lines of various tumour types, thereby partly explaining the resistance found (Mistry et al, 1991; Meijer et al, 1992) . It should be noted that we studied cell lines that were not treated in vitro to obtain acquired resistance. Because Yellin et al (1994) reported that the GSH levels in HNSCC cells can be up-regulated during cisplatin treatment, the GSH levels were also determined in the cell lines UM-SCC-14C, UM-SCC-35 and VU-SCC-OE after incubation with cisplatin during various time periods. As a result, only small increases in GSH levels occurred, but this did not lead to correlations with the IC50 values.
In the detoxification system GSH/GST, GSTs catalyse the binding of electrophilic components to GSH. Three isoforms of GST can be distinguished in humans namely ic (acidic), g (neutral) and x (basic). Expression of GSTs and MDR-related proteins was studied by immunocytochemistry. This was known to be a reliable method because for these proteins a correlation was found with the outcome of Western blots, immunoprecipitation analyses and the determination of the corresponding mRNA levels (Flens et al, 1994; Nooter et al, 1995; Scheffer et al, 1995) . Comparison of the GST staining indices of our eight HNSCC lines with the IC50 values of these lines revealed no correlation (see Table 2 ), which is in agreement with the results of Yellin and colleagues (1994) for a panel of 14 HNSCC lines. It cannot be excluded that the other factors in the GSH-associated detoxification system play a role in cisplatin sensitivity; this includes the enzymes glutathione peroxidase, glutathione synthetase, glutathione reductase and dipeptide gamma-glutamylcysteine (Kramer et al, 1988; Kurokawa et al, 1995) .
The importance of the MDR proteins in the efficacy of Ptcontaining chemotherapy has recently been reported for leukaemia cells and colon carcinomas (Ishikawa et al, 1994; 1996) . In the present study, no significant correlation was found between P-gp British Journal of Cancer (1998) 77(4), [556] [557] [558] [559] [560] [561] 0 Cancer Research Campaign 1998 expression levels and the IC50 values, suggesting no direct involvement of P-gp in the in vitro response of HNSCC cells to cisplatin. A significant, but inverse correlation was found between MRP and the IC50 values (Table 2) . MRP was detected on the membranes of HNSCC cells, as well as inside these cells, with the two antibodies MRP-m6 and MRP-rl. The staining results obtained with MRP-m6 were significantly correlated with those of MRP-rl, which is in line with results reported by Izquierdo et al (1996a) . It should be noted that these antibodies do not cross-react with human MDR1 and MDR3 P-gps (Flens et al, 1994) . A high expression of MRP is usually determined in cell lines with acquired resistance (Muller et al, 1994; Brock et al, 1995) . It is thought that MRP is a GS-X pump (Muller et al, 1994; Loe et al, 1996; O'Brien and Tew, 1996) , which is present on vesicles and/or the plasma membrane (Nooter et al, 1995) . The unexpected finding in our panel of HNSCC that the correlation of MRP with the IC 50 data was inverse (Fig 1) , and thus positive with sensitivity, and that high cellular Pt levels were associated with high MRP expression levels cannot be attributed to less active MRP because we provided evidence that the MRP was indeed active as determined by the functional MRP assay (see Table 3 ). These data implicate that in HNSCC cells the GS-X pump activity, i.e. transporting GSH-conjugated cisplatin out of cells, may not be the major function of MRP. This is in agreement with the results of De Vries et al, ( 1995) . A possible explanation for the unexpected relation of higher sensitivity in the presence of more MRP may be that endogenous metabolites conjugated to GSH are extruded from the cell, whereas cisplatin is counter-transported. Another hypothesis is the regulation of endogenous (ion) channels, and possibly other transporters, by MRP as described by Loe and colleagues (1996) , which can lead to an increase of the influx of cisplatin into the cells and eventually into the nucleus. As a consequence, the levels of DNA-bound Pt will increase. The involvement of other as yet undefined transport mechanisms in the sensitivity to cisplatin of the HNSCC lines under study also cannot be ruled out. Possible candidates for alternative pumps are the human canalicular multispecific organic anion transporter (cMOAT), also designed as MRP2. which has been described to be overexpressed in the cisplatin-resistant human head and neck cancer KB cell line (Taniguchi et al, 1996) and the SQM1 protein, which is present at reduced levels in HNSCC resistant to methotrexate and cisplatin (Bernal et al, 1990) .
High expression of the non-P-gp LRP protein in acute myeloid leukaemia and ovarian carcinoma has been associated with a poor response to chemotherapy, such as cisplatin treatment Scheffer et al, 1995) . In our HNSCC cell lines LRP was detectable, which is in agreement with the earlier published finding that this protein is present in epithelial cells and head and neck tumours (Izquierdo et al, 1996b) . No correlation was found between LRP expression levels and the IC 5 values (Table 2) , or with the Pt accumulation data. These results are in contrast with those found by Izquierdo and colleagues (1996a) , who showed a predictive value of LRP for in vitro sensitivity to several types of drugs, among which also cisplatin, in a number of cancer types. Their study, however, did not include HNSCC. Our results in eight HNSCC cell lines indicate that pump mechanisms other than LRP control the response of this cancer type to cisplatin. The importance of DNA damage recognition proteins in DNA repair and the nucleotide excision repair system in repairing cisplatin-DNA damage has been reviewed by Hill (1996) . It is clear also that other unknown factors may contribute to the differences in sensitivity to cisplatin in our HNSCC cell lines. In addition, it is obvious that intrinsic sensitivity to drugs is a very complex phenomenon that needs further investigation.
In conclusion, an inverse correlation was found between the IC 50 values of HNSCC cell lines, obtained after 72 h of cisplatin treatment, and their expression level of the MDR-associated membrane-bound protein MRP. In addition, the indications for a positive relation between Pt accumulation and MRP expression levels suggest that MRP plays a role in transport of cisplatin into or inside the HNSCC cells. ABBREVIATIONS BSA, bovine serum albumin; calcein-AM, calcein acetoxymethylester; GSH, glutathione; GST, glutathione S-transferase; GS-X, glutathione S-conjugate export pump; HNSCC, head and neck squamous cell carcinoma; IC 5 value, concentration of drug that inhibits cell growth to 50% of control growth; LRP, lung resistance protein; MAb, monoclonal antibody; MDR, multidrug resistance; MRP, multidrug resistance-associated protein; P-gp, P-glycoprotein; Pt, platinum.
